In the Health and Nature category, the HRA Pharma line offers innovative pharmaceutical solutions focused on reproductive health, wound healing, and intimate well-being, with products such as Norlevo, EllaOne, and Cicatridine. Designed to address specific medical needs, these treatments combine clinical efficacy, accessibility, and respect for the body’s natural processes, while ensuring optimal tolerability for users.
More detailsHRA Pharma is not a pharmaceutical company like any other. Founded in 1996 by André Ulmann, this independent European company quickly distinguished itself through its ability to address neglected medical needs. From the very beginning, HRA Pharma has made it its mission to develop accessible products, effective services, and innovative devices, placing people at the heart of everything it does. What propelled it into the spotlight? The 1999 launch of Norlevo, the very first emergency contraceptive pill, which was a game-changer for millions of women across Europe.
This forward-thinking approach didn’t stop at contraception. HRA Pharma went on to build a robust portfolio in key areas such as reproductive health and endocrinology. Through specialized products, the company aims to fill significant therapeutic gaps. It doesn’t just develop drugs; it creates personalized solutions, tailored to the needs of patients and healthcare professionals.
What truly sets HRA Pharma apart is its socially responsible model. Unlike large, impersonal multinational corporations, this pharmaceutical company has adopted a human-centered strategy based onlistening to patients, collaborating with healthcare professionals, and ethical marketing focused on accurate information and therapeutic education. It is a company that does not merely sell products but embodies a vision: that of healthcare that is more accessible, more equitable, and closer to people.
HRA Pharma’s headquarters are located in Paris, but its influence extends well beyond France’s borders. Thanks to local teams based in major European capitals—London, Rome, Madrid, and Bochum—the company is able to respond quickly to the needs of each local market while maintaining consistency in its overall mission. This European presence allows the company to combine local expertise with an international strategy—an essential asset in the highly regulated healthcare sector.
But beyond its structure, it is its human values that are HRA Pharma’s true strength. The company is built on a passionate team committed to building a future where every innovation makes a difference. It firmly believes that high-quality pharmaceutical research cannot exist without deep convictions and strong partnerships with the scientific community, public institutions, suppliers, and even other pharmaceutical companies. Every new project is designed to improve quality of life, and to that end, they do not hesitate to challenge the industry’s traditional models.
HRA Pharma embodies a new generation of pharmaceutical companies: innovation-driven, patient-centered, and committed to human and social values. It is redefining pharmaceutical standards by combining scientific rigor, responsible marketing, and global accessibility. A brand to watch very closely for anyone seeking effective, safe healthcare solutions designed to address real-world needs.
HRA Pharma focuses on precision, not quantity. Its product portfolio addresses very specific needs that are often overlooked by the traditional pharmaceutical industry. Here’s an overview of its main product lines:
Emergency Contraception
This line includes pills designed to prevent unplanned pregnancy after unprotected sex. It addresses an urgent, one-time, and essential need for millions of women worldwide.
Endocrinology
Here, HRA Pharma offers specialized treatments designed to combat rare conditions, such as adrenal cortical carcinoma or Cushing’s syndrome. These drugs are often orphan drugs, but they are crucial for the patients affected.
These product lines do more than just relieve symptoms or treat conditions—they literally change patients’ lives, often in cases where few solutions previously existed.
What makes HRA Pharma truly unique is its ability to think globally but act locally. Its products are available in many countries, but always with a special focus on cultural, medical, and regulatory adaptation. Their goal? To offer a tailored response to the specific challenges of each region, without ever compromising the scientific quality of their solutions.
The brand does not limit itself to the role of a mere manufacturer. It positions itself as an active partner in public health by participating in awareness campaigns, collaborating with NGOs, and supporting research projects. This open and collaborative approach strengthens its credibility and inspires trust.
Furthermore, HRA Pharma is committed to sustainable development. It implements concrete measures to reduce its environmental footprint: eco-designed packaging, short supply chains, and logistics optimization. Here again, the goal is clear: to protect patients’ health while respecting that of the planet.
And what about patients? The company’s products are designed with empathy, high standards, and accessibility in mind. Thanks to a consistent pricing policy and a strong partnership with pharmacies, HRA Pharma ensures that its treatments—no matter how specialized they may be—are available to as many people as possible. Because medication should never be a luxury.
